...
首页> 外文期刊>International Journal of Peptide Research and Therapeutics >Tripeptides with C-Terminal Arginine as Potential Inhibitors of Urokinase
【24h】

Tripeptides with C-Terminal Arginine as Potential Inhibitors of Urokinase

机译:具有C末端精氨酸作为尿激酶潜在抑制剂的三肽

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We synthesized and tested ten peptides with the molecular structure being H–d-Ser–AA–Arg–OH for their effect on the amidolytic activities against urokinase, thrombin, trypsin, plasmin, tissue plasminogen activator and kallikrein. The inserted amino acid in each peptide was either leucine, norleucine, izoleucine, valine, norvaline, α-metyloalanine, α-aminobutanoic acid, homoleucine, tert-leucine or neoglycine. H–d-Ser–NVal–Arg–OH (compound 4) was the most active inhibitor of urokinase plasminogen activator with a Ki value of 0.85 μM. Compound 4 showed cytotoxic effect against MDA-MB-231 and DLD cell lines, respectively, with IC50 values of 25 and 19 μM. Synthesised compounds did not have activity against MCF-7 cancer cells. These peptides were nontoxic against pig’s erythrocytes in vitro.
机译:我们合成并测试了10种分子结构为H–d-Ser–AA–Arg–OH的肽,它们对尿激酶,凝血酶,胰蛋白酶,纤溶酶,组织纤溶酶原激活物和激肽释放酶的酰胺分解活性有影响。每个肽中插入的氨基酸是亮氨酸,正亮氨酸,唑亮氨酸,缬氨酸,正缬氨酸,α-间丙氨酸,α-氨基丁酸,高亮氨酸,叔亮氨酸或新甘氨酸。 H–d-Ser–NVal–Arg–OH(化合物4)是尿激酶纤溶酶原激活剂最活跃的抑制剂,Ki 值为0.85μM。化合物4分别对MDA-MB-231和DLD细胞系具有细胞毒作用,IC50值分别为25和19μM。合成的化合物对MCF-7癌细胞没有活性。这些肽在体外对猪的红细胞无毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号